Elite Trades From Anywhere

$100 Off Your First Year

Claim Now
Last Close
17.51
Jun 30 • 04:00PM ET Dollar change-0.72 Percentage change(-3.92%)
Jun 29, 8:30 AMFT report on $1.5B point-of-care testing unit sale talks fuels 16% QDEL premarket surge
Index
RUT
Market Cap
1.19B
Enterprise Value
3.93B
Income
-1.21B
Sales
2.66B
Book/sh
27.19
Cash/sh
2.06
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
6500
IPO
Feb 01, 1991
P/E
-
Forward P/E
7.00
PEG
0.57
P/S
0.45
P/B
0.64
P/C
8.51
P/FCF
-
EV/EBITDA
9.13
EV/Sales
1.48
Quick Ratio
0.80
Current Ratio
1.43
Debt/Eq
1.55
LT Debt/Eq
1.41
Option/Short
Yes / Yes
EPS (ttm)
-17.82
EPS next Y
2.50
EPS next Q
-0.03
EPS this Y
-12.88%
EPS next Y
35.44%
EPS next 5Y
12.33%
EPS past 3/5Y
- -
Sales past 3/5Y
-5.81% 10.42%
EPS Y/Y TTM
-258.96%
Sales Y/Y TTM
-3.87%
EPS Q/Q
-615.20%
Sales Q/Q
-10.69%
Insider Own
1.18%
Insider Trans
3.06%
Inst Own
124.50%
Inst Trans
-3.16%
ROA
-20.03%
ROE
-49.95%
ROIC
-27.11%
Gross Margin
38.00%
Oper. Margin
-0.66%
Profit Margin
-45.55%
SMA20
24.35%
SMA50
38.00%
SMA200
-20.77%
Trades
Shs Outstand
68.10M
Shs Float
67.39M
52W High
35.58 -50.77%
52W Low
9.92 76.56%
Volatility
9.67% 8.39%
ATR (14)
1.37
RSI (14)
66.52
Beta
0.65
Rel Volume
0.71
Avg Volume
2.35M
Volume
1,657,406
Perf Week
46.75%
Perf Month
34.52%
Perf Quarter
14.78%
Perf Half Y
-40.22%
Perf YTD
-38.67%
Perf Year
-39.23%
Perf 3Y
-78.86%
Perf 5Y
-86.33%
Perf 10Y
-1.93%
Prev Close
18.23
Price
17.51
Change
-3.92%
Date Action Analyst Rating Change Price Target Change
May-07-26Downgrade Jefferies Buy → Hold $12.50
Oct-07-25Downgrade Citigroup Buy → Neutral $33
May-08-25Upgrade Jefferies Hold → Buy $44
Dec-11-24Upgrade Citigroup Neutral → Buy $44 → $50
Dec-10-24Initiated Jefferies Hold $43
Sep-19-24Resumed UBS Neutral $42 → $50
Sep-05-24Upgrade Craig Hallum Hold → Buy $40 → $57
Mar-04-24Downgrade UBS Neutral → Sell $70 → $42
Feb-14-24Downgrade JP Morgan Neutral → Underweight $66 → $37
Dec-11-23Downgrade Citigroup Buy → Neutral $95 → $72
Jun-29-26 02:04PM
Jun-23-26 07:12AM
Jun-02-26 07:12AM
May-21-26 09:18AM
May-20-26 07:00AM
09:45AM Loading…
May-07-26 09:45AM
May-05-26 08:20PM
04:31PM
04:05PM
Apr-23-26 09:32AM
Apr-20-26 07:56AM
07:12AM
Apr-16-26 11:43AM
09:49AM
05:23AM
04:15PM Loading…
Apr-15-26 04:15PM
Mar-24-26 07:00AM
Mar-02-26 11:07PM
Feb-19-26 09:17AM
Feb-18-26 11:33PM
04:05PM
12:36AM
Feb-17-26 11:12AM
Feb-16-26 06:59AM
01:00AM
Feb-12-26 09:45AM
09:25AM
08:30AM
12:00AM
Feb-11-26 06:39PM
05:25PM Loading…
05:25PM
04:56PM
04:27PM
04:05PM
Feb-09-26 10:04PM
Feb-04-26 10:00AM
Feb-03-26 07:12AM
Jan-28-26 11:02PM
Jan-27-26 11:04PM
Jan-22-26 07:12AM
Jan-21-26 07:00AM
Jan-15-26 10:37AM
Dec-18-25 09:17AM
Dec-11-25 10:32PM
Dec-03-25 11:45AM
Nov-25-25 01:00PM
Nov-24-25 07:00AM
Nov-21-25 05:15PM
Nov-20-25 09:00AM
Nov-12-25 12:35AM
Nov-06-25 01:25PM
11:37AM
09:16AM
12:12AM
Nov-05-25 04:54PM
04:52PM
04:05PM
Nov-03-25 10:04PM
07:00AM
Oct-30-25 08:25AM
Oct-29-25 07:30AM
Oct-23-25 06:45PM
12:44AM
Oct-22-25 07:00AM
Oct-20-25 01:36PM
Oct-16-25 08:30PM
Oct-07-25 11:30AM
Sep-30-25 09:30AM
Sep-26-25 09:53AM
Sep-25-25 09:00AM
Sep-23-25 11:31PM
Sep-22-25 07:00AM
Sep-18-25 11:30AM
Sep-10-25 12:20AM
Aug-28-25 07:30AM
Aug-21-25 04:30PM
09:00AM
Aug-19-25 04:05PM
Aug-18-25 12:02AM
Aug-14-25 11:13AM
Aug-13-25 03:00PM
12:10AM
Aug-12-25 11:59PM
Aug-08-25 09:45AM
Aug-07-25 09:40AM
Aug-06-25 01:02PM
03:36AM
Aug-05-25 05:57PM
05:14PM
04:10PM
Aug-04-25 01:32PM
Aug-03-25 11:12PM
Jul-29-25 05:00PM
Jul-28-25 12:01PM
Jul-24-25 09:00AM
Jul-22-25 04:30PM
Jul-18-25 03:10PM
Jul-17-25 07:00AM
Jul-16-25 09:39AM
Jul-14-25 07:00AM
QuidelOrtho Corp. operates as a vitro diagnostics company. It is focused on developing and manufacturing diagnostic products. The company was founded on May 27, 2022 and is headquartered in San Diego, CA.
PresidentMr. Brian J. Blaser
Chief Operations OfficerMr. Philip D. McLellan
Executive VP of Research & Development and CTOMr. Jonathan P. Siegrist Ph.D.
Vice President of Investor RelationsMs. Juliet C. Cunningham
Chief Legal Officer & Corporate SecretaryMr. Nathaniel B. Sisitsky Esq.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Strobeck MatthewDirectorFeb 13 '26Buy23.9610,000239,58627,775Feb 13 04:20 PM
Busky Joseph M.Chief Financial OfficerFeb 13 '26Buy23.663,37079,74210,290Feb 13 12:44 PM
Blaser Brian J.President and CEOFeb 13 '26Buy23.5910,540248,66140,073Feb 13 10:43 AM
RHOADS ANN DDirectorDec 10 '25Buy28.2775021,20615,021Dec 10 06:37 PM
Wilkins Joseph D Jr.DirectorNov 26 '25Buy27.9537010,34311,876Dec 01 04:33 PM
WIDDER KENNETH JDirectorNov 25 '25Option Exercise15.747,021110,51141,087Nov 25 04:16 PM
WIDDER KENNETH JDirectorNov 25 '25Sale27.814,026111,96537,061Nov 25 04:16 PM
KENNETH WIDDERDirectorNov 25 '25Proposed Sale27.814,026111,965Nov 25 04:11 PM
Busky Joseph M.Chief Financial OfficerNov 24 '25Buy26.064,770124,3056,920Nov 25 01:21 PM
POLAN MARY LAKE PH DDirectorNov 21 '25Buy22.431,00022,43012,640Nov 24 04:09 PM
Blaser Brian J.President and CEONov 19 '25Buy21.3423,500501,57729,533Nov 20 04:16 PM
BUECHLER KENNETH FDirectorJul 15 '25Option Exercise15.749,215145,044101,921Jul 17 04:09 PM